Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
6446 studies found for:    "Urologic Diseases"
Show Display Options
Rank Status Study
1 Completed Long-Term Lead Chelation Therapy and Progressive Renal Insufficiency
Condition: Urologic Disease
Intervention: Drug: calcium disodium EDTA (edetate calcium disodium)
2 Completed Efficacy and Tolerability of Propiverine Hydrochloride in Patients With Neurogenic Detrusor Overactivity
Conditions: Neurogenic Urinary Bladder Disorder;   Urinary Bladder, Neurogenic;   Bladder Disorder, Neurogenic;   Urinary Bladder Disorder, Neurogenic;   Neurogenic Bladder Disorder;   Urinary Bladder Neurogenic Dysfunction;   Urologic Diseases;   Overactive Detrusor Function;   Urinary Incontinence
Interventions: Drug: Propiverine hydrochloride ER (extended release);   Drug: Propiverine hydrochloride IR (immediate release)
3 Not yet recruiting Autologous Cell Therapy for Stress Urinary Incontinence in Males Following Prostate Surgery
Conditions: Urinary Incontinence;   Stress;   Urination Disorders;   Urologic Diseases;   Lower Urinary Tract Symptoms;   Urological Manifestations
Intervention: Biological: autologous muscle-derived cells (AMDC)
4 Completed A Study to Evaluate the Efficacy, Safety and Tolerability of Mirabegron and Solifenacin Alone and in Combination for the Treatment of Overactive Bladder
Conditions: Urinary Bladder, Overactive;   Urinary Bladder Diseases;   Urologic Diseases;   Urological Manifestations;   Signs and Symptoms
Interventions: Drug: Solifenacin succinate and Mirabegron;   Drug: Mirabegron;   Drug: Solifenacin succinate;   Drug: Placebo
5 Completed A Study of the Safety and Effectiveness of Oral Levofloxacin Compared With Oral Ciprofloxacin in the Treatment of Complicated Urinary Tract Infections
Conditions: Urinary Tract Infections;   Bacteriuria;   Urologic Diseases;   Pyelonephritis;   Neurogenic Bladder
Intervention: Drug: Levofloxacin
6 Unknown  Clinical Study to Investigate the Safety and Pharmacokinetics of SK3530 Tablet in Renal Impaired Male Patients
Conditions: Renal Insufficiency;   Kidney Diseases;   Urologic Diseases
Intervention: Drug: Mirodenafil
7 Completed Clinical Study to Investigate the Safety and Pharmacokinetics of Udenafil Tablet in Renal Impaired Male Patients
Conditions: Renal Insufficiency;   Kidney Diseases;   Urologic Diseases
Intervention: Drug: Udenafil
8 Completed Emergence Agitation Between Sevoflurane and Desflurane in Pediatric
Conditions: Children;   Urologic Diseases;   Ambulation Difficulty
Interventions: Drug: Desflurane;   Drug: Sevoflurane
9 Completed
Has Results
Effect of Remote Ischaemic Preconditioning on Renal Function in Patients Undergoing Living Donor Kidney Transplantation
Conditions: Kidney Diseases;   Kidney Failure, Chronic;   Kidney Failure;   Renal Insufficiency;   Renal Insufficiency, Chronic;   Urologic Diseases
Intervention: Device: remote ischaemic preconditioning
10 Active, not recruiting Effects of a Cranberry Beverage on Women With Recent History of Urinary Tract Infections
Conditions: Urinary Tract Infections;   Infection;   Urologic Diseases
Interventions: Other: cranberry juice;   Other: placebo beverage
11 Recruiting Bioequivalence Study of the Second Generation Dutasteride and Tamsulosin HCl Combination Capsule in Fed State
Condition: Urologic Diseases
Interventions: Drug: Commercially available combination of dutasteride 0.5 mg and tamsulosin HCL 0.4 mg;   Drug: Second generation dutasteride 0.5 mg and tamsulosin HCL 0.4 mg combination capsule
12 Terminated A Study to Evaluate the Pain Relieving Effects, Safety, and Tolerability of JNJ-42160443 for the Relief of Bladder Pain
Conditions: Cystitis, Interstitial;   Urologic Diseases;   Urinary Bladder Diseases;   Cystitis
Interventions: Drug: Placebo;   Drug: JNJ-42160443
13 Recruiting A Trial Comparing Combination Treatment (Solifenacin Plus Mirabegron) With One Treatment Alone (Solifenacin)
Conditions: Urinary Bladder Overactive;   Urinary Bladder Diseases;   Urologic Diseases
Interventions: Drug: Mirabegron;   Drug: Solifenacin succinate low dose;   Drug: Solifenacin succinate high dose
14 Completed A Study of the Safety and Effectiveness of Levofloxacin Compared With Lomefloxacin in the Treatment of Complicated Urinary Tract Infections
Conditions: Urinary Tract Infections;   Bacterial Infections;   Bacteriuria;   Urologic Diseases
Intervention: Drug: Levofloxacin
15 Completed A Study to Evaluate the Efficacy and Safety of Mirabegron Compared to Solifenacin in Patients With Overactive Bladder Who Are Previously Treated With Another Medicine But Were Not Satisfied With That Treatment
Conditions: Urinary Bladder, Overactive;   Urinary Bladder Diseases;   Urologic Diseases
Interventions: Drug: Mirabegron;   Drug: Solifenacin succinate
16 Recruiting Bioequivalence Study of the Second Generation Dutasteride and Tamsulosin Hydrochloride (HCL) Combination Capsule in Fasted State
Condition: Urologic Diseases
Interventions: Drug: Commercially available combination of dutasteride 0.5 mg and tamsulosin HCL 0.4 mg;   Drug: Second generation dutasteride 0.5 mg and tamsulosin HCL 0.4 mg combination capsule
17 Completed A Randomized Study Comparing Placebo and ASP3652 in the Treatment of Women With Bladder Pain Syndrome / Interstitial Cystitis (BPS/IC)
Conditions: Cystitis, Interstitial;   Urologic Diseases;   Urinary Bladder Disease;   Pain
Interventions: Drug: ASP3652;   Drug: Placebo
18 Enrolling by invitation Chart Review of Those Who Have Had Open, Laparoscopic, Ureteroscopic, or Percutaneous Surgery
Condition: Urologic Diseases
Intervention:
19 Unknown  Pharmacology and Physiology of the Lower Urinary Tract
Condition: Urologic Diseases
Intervention:
20 Terminated Hyperthermia Treatment in Conjunction With Mitomycin C Versus Bacillus Calmette-Guérin Immunotherapy (BCG) for Superficial Bladder Cancer
Conditions: Urinary Bladder Diseases;   Urinary Bladder Neoplasms;   Urinary Bladder Cancer;   Malignant Tumor of Urinary Bladder;   Urologic Diseases;   Urologic Neoplasms;   Neoplasms;   Neoplasms by Site
Interventions: Device: Synergo + MMC;   Drug: Bacillus Calmette-Guérin

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years